FDA.report

Application 090199

Type
ANDA
Sponsor
TEVA PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001LEVOCETIRIZINE DIHYDROCHLORIDELEVOCETIRIZINE DIHYDROCHLORIDETABLET;ORAL5MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7701Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7701Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7701Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7701Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7701Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
43063-479Levocetirizine DihydrochlorideLevocetirizine DihydrochloridePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-479Levocetirizine DihydrochlorideLevocetirizine DihydrochloridePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-479Levocetirizine DihydrochlorideLevocetirizine DihydrochloridePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-479Levocetirizine DihydrochlorideLevocetirizine DihydrochloridePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-479Levocetirizine DihydrochlorideLevocetirizine DihydrochloridePD-Rx Pharmaceuticals, Inc.ANDACurrent
50090-3698Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideA-S Medication SolutionsANDACurrent
50090-3698Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideA-S Medication SolutionsANDACurrent
50090-3698Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideA-S Medication SolutionsANDACurrent
66336-720Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideDispensing Solutions, Inc.ANDACurrent
71335-1405Levocetirizine DihydrochlorideLevocetirizine DihydrochlorideBryant Ranch PrepackANDACurrent